Business
Phio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of Stockholders
MARLBOROUGH, Mass., Oct. 11, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of
About this update from Phio Pharmaceuticals Corp.
[{"type":"text","content":"MARLBOROUGH, Mass., Oct. 11, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, announced today that its 2019 Annual Meeting of Stockholders, scheduled for October 10, 2019, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved. The Annual Meeting will be reconvened at 9:00 a.m. (Eastern Time) at the Company's executive offices on October 24, 2019 to allow more opportunity for stockholders to vote on all proposals described in the Company's definitive proxy statement filed with the Securities and Exchange Commission (SEC) on August 30, 2019.\nLogo - https://mma.prnewswire.com/media/786567/Phio_Pharmaceuticals_Logo.jpg\nThe Company encourages any stockholder that has not received communications from their brokers or banks or is uncertain if its shares have been voted to contact the Company's proxy specialists at the number listed below in order to help facilitate the voting of shares.\nIn order for the Company to achieve quorum, the Company's board of directors and management respectfully requests all such holders as of the record date to please vote their proxies as soon as possible, but no later than October 23, 2019 at 11:59 p.m. (Eastern Time). The Company also reminds holders to inquire with their voting institutions about any additional clearing time that may be required to forward voting instructions to the Company in advance of the October 23, 2019 deadline. The record date for the Annual Meeting remains August 21, 2019. Company stockholders as of the record date can vote, even if they have subsequently sold their shares. Stockholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action.\nFor questions relating to the voting of shares or to request additional or misplaced proxy voting materials, the Company's proxy solicitor, Georgeson, may be reached at 1-866-695-6078 between the hours of 9:00 a.m. and 11:00 p.m. Eastern Time Monday through Friday.\nStockholders who hold their shares through a bank or broker can vote through Broadridge using one of the methods below:\nVote Online:\nGo to www.proxyvote.com. Have your ...